Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.

Pei S, Pollyea DA, Gustafson A, Stevens BM, Minhajuddin M, Fu R, Riemondy KA, Gillen AE, Sheridan RM, Kim J, Costello JC, Amaya ML, Inguva A, Winters A, Ye H, Krug A, Jones CL, Adane B, Khan N, Ponder J, Schowinsky J, Abbott D, Hammes A, Myers JR, Ashton JM, Nemkov T, D'Alessandro A, Gutman JA, Ramsey HE, Savona MR, Smith CA, Jordan CT.

Cancer Discov. 2020 Jan 23. doi: 10.1158/2159-8290.CD-19-0710. [Epub ahead of print]

PMID:
31974170
2.

Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.

Shoda T, Wen T, Caldwell JM, Collins MH, Besse JA, Osswald GA, Abonia JP, Arva NC, Atkins D, Capocelli KE, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Mukkada VA, Putnam PE, Sheridan RM, Rudman Spergel AK, Spergel JM, Wechsler JB, Yang GY, Aceves SS, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

J Allergy Clin Immunol. 2020 Jan;145(1):255-269. doi: 10.1016/j.jaci.2019.11.007. Epub 2019 Nov 16.

PMID:
31738990
3.

Control of RNA Pol II Speed by PNUTS-PP1 and Spt5 Dephosphorylation Facilitates Termination by a "Sitting Duck Torpedo" Mechanism.

Cortazar MA, Sheridan RM, Erickson B, Fong N, Glover-Cutter K, Brannan K, Bentley DL.

Mol Cell. 2019 Dec 19;76(6):896-908.e4. doi: 10.1016/j.molcel.2019.09.031. Epub 2019 Oct 30.

PMID:
31677974
4.

Rotavirus Reassortant-Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia.

Mohanty SK, Lobeck I, Donnelly B, Dupree P, Walther A, Mowery S, Coots A, Bondoc A, Sheridan RM, Poling HM, Temple H, McNeal M, Sestak K, Bansal R, Tiao G.

Hepatology. 2019 Aug 23. doi: 10.1002/hep.30907. [Epub ahead of print]

PMID:
31442322
5.

Radiation Dose Monitoring for Fluoroscopically Guided Interventional Procedures: Effect on Patient Radiation Exposure.

Liu B, Hirsch JA, Li X, Sheridan RM, Rehani MM, Zheng H, Rabinov JD.

Radiology. 2019 Mar;290(3):744-749. doi: 10.1148/radiol.2019180799. Epub 2019 Jan 15.

PMID:
30644807
6.

Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology-pathology case series.

Engelhardt EM, Trout AT, Sheridan RM, Veldtman GR, Dillman JR.

Congenit Heart Dis. 2019 May;14(3):380-388. doi: 10.1111/chd.12730. Epub 2018 Dec 20.

PMID:
30569564
7.

Widespread Backtracking by RNA Pol II Is a Major Effector of Gene Activation, 5' Pause Release, Termination, and Transcription Elongation Rate.

Sheridan RM, Fong N, D'Alessandro A, Bentley DL.

Mol Cell. 2019 Jan 3;73(1):107-118.e4. doi: 10.1016/j.molcel.2018.10.031. Epub 2018 Nov 29.

8.

Dynamic turnover of paused Pol II complexes at human promoters.

Erickson B, Sheridan RM, Cortazar M, Bentley DL.

Genes Dev. 2018 Sep 1;32(17-18):1215-1225. doi: 10.1101/gad.316810.118. Epub 2018 Aug 27.

9.

Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.

Trout AT, Sheridan RM, Serai SD, Xanthakos SA, Su W, Zhang B, Wallihan DB.

Radiology. 2018 Jun;287(3):824-832. doi: 10.1148/radiol.2018172099. Epub 2018 Feb 22.

PMID:
29470938
10.

valr: Reproducible genome interval analysis in R.

Riemondy KA, Sheridan RM, Gillen A, Yu Y, Bennett CG, Hesselberth JR.

F1000Res. 2017 Jun 29;6:1025. doi: 10.12688/f1000research.11997.1. eCollection 2017.

11.

3D printed pathological sectioning boxes to facilitate radiological-pathological correlation in hepatectomy cases.

Trout AT, Batie MR, Gupta A, Sheridan RM, Tiao GM, Towbin AJ.

J Clin Pathol. 2017 Nov;70(11):984-987. doi: 10.1136/jclinpath-2016-204293. Epub 2017 Jun 8.

PMID:
28596154
12.

RNA Pol II Dynamics Modulate Co-transcriptional Chromatin Modification, CTD Phosphorylation, and Transcriptional Direction.

Fong N, Saldi T, Sheridan RM, Cortazar MA, Bentley DL.

Mol Cell. 2017 May 18;66(4):546-557.e3. doi: 10.1016/j.molcel.2017.04.016. Epub 2017 May 11.

13.

Cellular neurothekeoma of the eyelid in a 6-year-old boy.

Gray ME, Palileo CM, Sheridan RM.

J AAPOS. 2016 Aug;20(4):374-6. doi: 10.1016/j.jaapos.2016.03.014. Epub 2016 Jun 16.

PMID:
27318210
14.

Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.

Saldi T, Cortazar MA, Sheridan RM, Bentley DL.

J Mol Biol. 2016 Jun 19;428(12):2623-2635. doi: 10.1016/j.jmb.2016.04.017. Epub 2016 Apr 20. Review.

15.

Revenue Potential for Inpatient IR Consultation Services: A Financial Model.

Misono AS, Mueller PR, Hirsch JA, Sheridan RM, Siddiqi AU, Liu RW.

J Vasc Interv Radiol. 2016 May;27(5):658-664.e1. doi: 10.1016/j.jvir.2016.01.144. Epub 2016 Apr 11.

PMID:
27080010
16.

Sedation shared decision-making in ambulatory venous access device placement: Effects on patient choice, satisfaction and recovery time.

Chittle MD, Oklu R, Pino RM, He P, Sheridan RM, Martino J, Hirsch JA.

Vasc Med. 2016 Aug;21(4):355-60. doi: 10.1177/1358863X16643602. Epub 2016 Apr 13.

PMID:
27076197
17.

Selectable one-step PCR-mediated integration of a degron for rapid depletion of endogenous human proteins.

Sheridan RM, Bentley DL.

Biotechniques. 2016 Feb 1;60(2):69-74. doi: 10.2144/000114378. eCollection 2016 Feb.

18.

A dynamic RNA loop in an IRES affects multiple steps of elongation factor-mediated translation initiation.

Ruehle MD, Zhang H, Sheridan RM, Mitra S, Chen Y, Gonzalez RL, Cooperman BS, Kieft JS.

Elife. 2015 Nov 2;4. pii: e08146. doi: 10.7554/eLife.08146.

19.

Effects of Transcription Elongation Rate and Xrn2 Exonuclease Activity on RNA Polymerase II Termination Suggest Widespread Kinetic Competition.

Fong N, Brannan K, Erickson B, Kim H, Cortazar MA, Sheridan RM, Nguyen T, Karp S, Bentley DL.

Mol Cell. 2015 Oct 15;60(2):256-67. doi: 10.1016/j.molcel.2015.09.026.

20.

An overview of clinical associate roles in the neurointerventional specialty.

Chittle MD, Vanderboom T, Borsody-Lotti J, Ganguli S, Hanley P, Martino J, Mueller P, Penzias A, Saltalamacchia C, Sheridan RM, Hirsch JA.

J Neurointerv Surg. 2016 Mar;8(3):323-7. doi: 10.1136/neurintsurg-2014-011576. Epub 2015 Jan 5. Review.

PMID:
25561584
21.

Multifocal hepatic neoplasia in 3 children with APC gene mutation.

Gupta A, Sheridan RM, Towbin A, Geller JI, Tiao G, Bove KE.

Am J Surg Pathol. 2013 Jul;37(7):1058-66. doi: 10.1097/PAS.0b013e31828aeb18.

PMID:
23715166
22.

Recombinant strains for the enhanced production of bioengineered rapalogs.

Kendrew SG, Petkovic H, Gaisser S, Ready SJ, Gregory MA, Coates NJ, Nur-E-Alam M, Warneck T, Suthar D, Foster TA, McDonald L, Schlingman G, Koehn FE, Skotnicki JS, Carter GT, Moss SJ, Zhang MQ, Martin CJ, Sheridan RM, Wilkinson B.

Metab Eng. 2013 Jan;15:167-73. doi: 10.1016/j.ymben.2012.11.001. Epub 2012 Nov 17.

PMID:
23164580
23.

Abnormal expression of transcription factor activator protein-2α in pathologic placentas.

Sheridan RM, Stanek J, Khoury J, Handwerger S.

Hum Pathol. 2012 Nov;43(11):1866-74. doi: 10.1016/j.humpath.2012.01.011. Epub 2012 May 9.

24.

Multiple dysplastic liver nodules in PFIC2 underscore risk for neoplasia associated with functional BSEP deficiency.

Sheridan RM, Gupta A, Miethke A, Knisely AS, Bove KE.

Am J Surg Pathol. 2012 May;36(5):785-6. doi: 10.1097/PAS.0b013e3182500c35. No abstract available.

PMID:
22472955
25.

Team training: a safer future for neurointerventional practice.

Miguel K, Hirsch JA, Sheridan RM.

J Neurointerv Surg. 2011 Sep;3(3):285-7. doi: 10.1136/jnis.2010.003590. Epub 2011 Jan 10.

PMID:
21990843
26.

Establishing operational stability--developing human infrastructure.

Gomez MA, Byers EJ, Stingley P, Sheridan RM, Hirsch JA.

J Neurointerv Surg. 2010 Dec;2(4):379-84. doi: 10.1136/jnis.2010.002212. Epub 2010 Oct 22.

PMID:
21990652
27.

Ductus arteriosus aneurysm with massive thrombosis of pulmonary artery and fetal hydrops.

Sheridan RM, Michelfelder EC, Choe KA, Divanovic A, Liu C, Ware S, Stanek J.

Pediatr Dev Pathol. 2012 Jan-Feb;15(1):79-85. doi: 10.2350/11-02-0991-CR.1. Epub 2011 Aug 29.

PMID:
21875340
28.

Placental fetal thrombotic vasculopathy in severe congenital anomalies prompting EXIT procedure.

Stanek J, Sheridan RM, Le LD, Crombleholme TM.

Placenta. 2011 May;32(5):373-9. doi: 10.1016/j.placenta.2011.02.002. Epub 2011 Mar 23.

PMID:
21435717
29.

Radiofrequency identification for inventory in neurointerventional practice.

Byers E, Gomez MA 2nd, Sheridan RM, Orr NW, Hirsch JA.

J Am Coll Radiol. 2011 Mar;8(3):191-8. doi: 10.1016/j.jacr.2010.09.006.

PMID:
21371670
30.

Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited.

Maugans T, Sheridan RM, Adams D, Gupta A.

Neurosurgery. 2011 Jul;69(1):112-8; discussion 118. doi: 10.1227/NEU.0b013e3182134360.

PMID:
21368703
31.

von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.

Yi Y, Mikhaylova O, Mamedova A, Bastola P, Biesiada J, Alshaikh E, Levin L, Sheridan RM, Meller J, Czyzyk-Krzeska MF.

Clin Cancer Res. 2010 Nov 1;16(21):5142-52. doi: 10.1158/1078-0432.CCR-09-3416. Epub 2010 Oct 26.

32.

Multifocal synchronous ipsilateral Warthin tumors: case report and review of the literature.

Hall JE, Statham MM, Sheridan RM, Wilson KM.

Ear Nose Throat J. 2010 Sep;89(9):E1-3. Review.

PMID:
20859854
33.

Applying the lean management philosophy to neurointerventional radiology.

Gomez MA 2nd, Hirsch JA, Stingley P, Byers E, Sheridan RM.

J Neurointerv Surg. 2010 Mar;2(1):83-6. doi: 10.1136/jnis.2009.002162. Review. No abstract available.

PMID:
21990566
34.

Engineered biosynthesis of hybrid macrolide polyketides containing D-angolosamine and D-mycaminose moieties.

Schell U, Haydock SF, Kaja AL, Carletti I, Lill RE, Read E, Sheehan LS, Low L, Fernandez MJ, Grolle F, McArthur HA, Sheridan RM, Leadlay PF, Wilkinson B, Gaisser S.

Org Biomol Chem. 2008 Sep 21;6(18):3315-27. doi: 10.1039/b807914e. Epub 2008 Jul 28.

PMID:
18802638
35.

Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.

Zhang MQ, Gaisser S, Nur-E-Alam M, Sheehan LS, Vousden WA, Gaitatzis N, Peck G, Coates NJ, Moss SJ, Radzom M, Foster TA, Sheridan RM, Gregory MA, Roe SM, Prodromou C, Pearl L, Boyd SM, Wilkinson B, Martin CJ.

J Med Chem. 2008 Sep 25;51(18):5494-7. doi: 10.1021/jm8006068.

PMID:
18800759
36.

Engineering of the spinosyn PKS: directing starter unit incorporation.

Sheehan LS, Lill RE, Wilkinson B, Sheridan RM, Vousden WA, Kaja AL, Crouse GD, Gifford J, Graupner PR, Karr L, Lewer P, Sparks TC, Leadlay PF, Waldron C, Martin CJ.

J Nat Prod. 2006 Dec;69(12):1702-10.

PMID:
17190446
37.

Rapamycin biosynthesis: Elucidation of gene product function.

Gregory MA, Hong H, Lill RE, Gaisser S, Petkovic H, Low L, Sheehan LS, Carletti I, Ready SJ, Ward MJ, Kaja AL, Weston AJ, Challis IR, Leadlay PF, Martin CJ, Wilkinson B, Sheridan RM.

Org Biomol Chem. 2006 Oct 7;4(19):3565-8. Epub 2006 Aug 22.

PMID:
16990929
38.

Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.

Wilkinson B, Gregory MA, Moss SJ, Carletti I, Sheridan RM, Kaja A, Ward M, Olano C, Mendez C, Salas JA, Leadlay PF, vanGinckel R, Zhang MQ.

Bioorg Med Chem Lett. 2006 Nov 15;16(22):5814-7. Epub 2006 Sep 8.

PMID:
16962775
39.

Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues.

Moss SJ, Carletti I, Olano C, Sheridan RM, Ward M, Math V, Nur-E-Alam M, Braña AF, Zhang MQ, Leadlay PF, Méndez C, Salas JA, Wilkinson B.

Chem Commun (Camb). 2006 Jun 14;(22):2341-3. Epub 2006 May 11.

PMID:
16733573
40.

Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis.

Gregory MA, Petkovic H, Lill RE, Moss SJ, Wilkinson B, Gaisser S, Leadlay PF, Sheridan RM.

Angew Chem Int Ed Engl. 2005 Jul 25;44(30):4757-60. No abstract available.

PMID:
15977283
41.

Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tü4055: insights into nitrile formation.

Olano C, Moss SJ, Braña AF, Sheridan RM, Math V, Weston AJ, Méndez C, Leadlay PF, Wilkinson B, Salas JA.

Mol Microbiol. 2004 Jun;52(6):1745-56.

42.

Isolation and characterization of pre-rapamycin, the first macrocyclic intermediate in the biosynthesis of the immunosuppressant rapamycin by S. hygroscopicus.

Gregory MA, Gaisser S, Lill RE, Hong H, Sheridan RM, Wilkinson B, Petkovic H, Weston AJ, Carletti I, Lee HL, Staunton J, Leadlay PF.

Angew Chem Int Ed Engl. 2004 May 3;43(19):2551-3. No abstract available.

PMID:
15127450
43.

Heterologous expression in Saccharopolyspora erythraea of a pentaketide synthase derived from the spinosyn polyketide synthase.

Martin CJ, Timoney MC, Sheridan RM, Kendrew SG, Wilkinson B, Staunton JC, Leadlay PF.

Org Biomol Chem. 2003 Dec 7;1(23):4144-7. Epub 2003 Oct 29.

PMID:
14685317
44.

Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272.

Gaisser S, Kellenberger L, Kaja AL, Weston AJ, Lill RE, Wirtz G, Kendrew SG, Low L, Sheridan RM, Wilkinson B, Galloway IS, Stutzman-Engwall K, McArthur HA, Staunton J, Leadlay PF.

Org Biomol Chem. 2003 Aug 21;1(16):2840-7.

PMID:
12968333
45.

A novel erythromycin, 6-desmethyl erythromycin D, made by substituting an acyltransferase domain of the erythromycin polyketide synthase.

Petkovic H, Lill RE, Sheridan RM, Wilkinson B, McCormick EL, McArthur HA, Staunton J, Leadlay PF, Kendrew SG.

J Antibiot (Tokyo). 2003 Jun;56(6):543-51.

46.

Engineered biosynthesis of novel spinosyns bearing altered deoxyhexose substituents.

Gaisser S, Martin CJ, Wilkinson B, Sheridan RM, Lill RE, Weston AJ, Ready SJ, Waldron C, Crouse GD, Leadlay PF, Staunton J.

Chem Commun (Camb). 2002 Mar 21;(6):618-9.

PMID:
12120151
47.
48.

The rapid papainisation of red cells for the detection of Rh antibodies.

Izatt MM, Blue AM, Muir W, Sheridan RM, Morrison CJ.

Vox Sang. 1969 Aug;17(2):157-60. No abstract available.

PMID:
4981771

Supplemental Content

Loading ...
Support Center